Effects of three modifiers of glycolysis on ATP, lactate, hypoxia, and growth in human tumor cell lines in vivo

Strahlentherapie und Onkologie

Volumn 188, Issue 5, 2012, Pages 431-437

  Yaromina, A ^a   Meyer, S ^b   Fabian, C ^b   Zaleska, K ^a,c   Sattler, U G A ^b   Kunz Schughart, L A ^d   Mueller Klieser, W ^b   Zips, D ^a,e   Baumann, M ^a,e  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c GREATER POLAND CANCER CENTER   (Poland)

^d Helmholtz Zentrum Dresden Rossendorf   (Germany)

^e UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Glycolysis; Growth delay; Human tumor xenograft; Neoplasms; Tumor micromilieu

Indexed keywords

1 ALPHA CYANO 4 HYDROXYCINNAMATE; ADENOSINE TRIPHOSPHATE; DICHLOROACETIC ACID; KI 67 ANTIGEN; LACTIC ACID; MONOCARBOXYLATE TRANSPORTER; OXAMIC ACID; UNCLASSIFIED DRUG; ALPHA CYANO 4 HYDROXYCINNAMIC ACID; ALPHA-CYANO-4-HYDROXYCINNAMATE; COUMARIC ACID; ENZYME INHIBITOR;

ACIDIFICATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFECT; FEMALE; GLYCOLYSIS; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; TUMOR CELL LINE; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; CELL PROLIFERATION; GENE EXPRESSION REGULATION; METABOLISM; PH; XENOGRAFT;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; COUMARIC ACIDS; DICHLOROACETATE; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOLYSIS; HUMANS; HYDROGEN-ION CONCENTRATION; LACTIC ACID; MICE; OXAMIC ACID; OXYGEN CONSUMPTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84862676783     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-0054-3     Document Type: Article

References (39)

1. Bonnet S, Archer SL, Allalunis-Turner J et al (2007) A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11:37-51 (Pubitemid 46054520)
2. Brizel DM, Schroeder T, Scher RL et al (2001) Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 51:349-353 (Pubitemid 32884281)
3. Brooks GA, Dubouchaud H, Brown M et al (1999) Role of mitochondrial lactate dehydrogenase and lactate oxidation in the intracellular lactate shuttle. Proc Natl Acad Sci U S A 96:1129-1134 (Pubitemid 29072195)
4. Cairns RA, Bennewith KL, Graves EE et al (2009) Pharmacologically increased tumor hypoxia can be measured by 18 F-fluoroazomycin arabinoside positron emission tomography and enhances tumor response to hypoxic cytotoxin PR-104. Clin Cancer Res 15:7170-7174
5. Cairns RA, Papandreou I, Sutphin PD et al (2007) Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy. Proc Natl Acad Sci U S A 104:9445-9450 (Pubitemid 47185799)
6. Chen Y, Cairns R, Papandreou I et al (2009) Oxygen consumption can regulate the growth of tumors, a new perspective on the Warburg effect. PLoS One 4:e7033
7. Chretien D, Pourrier M, Bourgeron T et al (1995) An improved spectrophotometric assay of pyruvate dehydrogenase in lactate dehydrogenase contaminated mitochondrial preparations from human skeletal muscle. Clin Chim Acta 240:129-136
8. Coe EL, Strunk RC (1970) The effect of oxamate on glycolysis in intact ascites tumor cells. I. Kinetic evidence for a dual glycolytic system. Biochim Biophys Acta 208:189-202
9. DeBerardinis RJ, Lum JJ, Hatzivassiliou G et al (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7:11-20
10. Deberardinis RJ, Sayed N, Ditsworth D et al (2008) Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 18:54-61 (Pubitemid 351694453)
11. Elwood JC (1968) Effect of oxamate on glycolysis and respiration in sarcoma 37 ascites cells. Cancer Res 28:2056-2060
12. Ferrick DA, Neilson A, Beeson C (2008) Advances in measuring cellular bioenergetics using extracellular flux. Drug Discov Today 13:268-274
13. Halestrap AP, Price NT (1999) The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J 343(Pt 2):281-299 (Pubitemid 29511759)
14. Maftei CA, Bayer C, Shi K et al (2011) Quantitative assessment of hypoxia subtypes in microcirculatory supply units of malignant tumors using (immuno-) fluorescence techniques. Strahlenther Onkol 187:260-266
15. Manning Fox JE, Meredith D, Halestrap AP (2000) Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle. J Physiol 529(Pt 2):285-293 (Pubitemid 32040847)
16. Michelakis ED, Webster L, Mackey JR (2008) Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. Br J Cancer 99:989-994
17. Mueller-Klieser W, Walenta S (1993) Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging. Histochem J 25:407-420 (Pubitemid 23181269)
18. Papaconstantinou J, Colowick SP (1961) The role of glycolysis in the growth of tumor cells. II. The effect of oxamic acid on the growth of HeLa cells in tissue culture. J Biol Chem 236:285-288
19. Papandreou I, Goliasova T, Denko NC (2010) Anticancer drugs that target metabolism: is dichloroacetate the new paradigm? Int J Cancer 128:1001-1008
20. Quennet V, Yaromina A, Zips D et al (2006) Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice. Radiother Oncol 81:130-135 (Pubitemid 44780779)
21. Sattler UG, Hirschhaeuser F, Mueller-Klieser WF (2010) Manipulation of glycolysis in malignant tumors: fantasy or therapy? Curr Med Chem 17:96-108
22. Sattler UG, Meyer SS, Quennet V et al (2010) Glycolytic metabolism and tumour response to fractionated irradiation. Radiother Oncol 94:102-109
23. Sattler UG, Mueller-Klieser W (2009) The anti-oxidant capacity of tumour glycolysis. Int J Radiat Biol 85:963-971
24. Secomb TW, Hsu R, Ong ET et al (1995) Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors. Acta Oncol 34:313-316
25. Semenza GL (2009) Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol 19:12-16
26. Shahrzad S, Lacombe K, Adamcic U et al (2010) Sodium dichloroacetate (DCA) reduces apoptosis in colorectal tumor hypoxia. Cancer Lett 297:75-83
27. Sonveaux P, Vegran F, Schroeder T et al (2008) Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 118:3930-3942
28. Staab A, Fleischer M, Loeffler J et al (2011) Small interfering RNA targeting HIF-1alpha reduces hypoxia- dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro. Strahlenther Onkol 187:252-259
29. Stacpoole PW, Nagaraja NV, Hutson AD (2003) Efficacy of dichloroacetate as a lactate-lowering drug. J Clin Pharmacol 43:683-6691
30. Strofer M, Jelkmann W, Depping R (2011) Curcumin decreases survival of Hep3B liver and MCF-7 breast cancer cells: the role of HIF. Strahlenther Onkol 187:393-400
31. Thornburg JM, Nelson KK, Clem BF et al (2008) Targeting aspartate aminotransferase in breast cancer. Breast Cancer Res 10:R84
32. Vaupel P, Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26:225-239 (Pubitemid 47101660)
33. Walenta S, Chau TV, Schroeder T et al (2003) Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists? J Cancer Res Clin Oncol 129:321-326 (Pubitemid 36963193)
34. Walenta S, Wetterling M, Lehrke M et al (2000) High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 60:916-921 (Pubitemid 30129526)
35. Wu M, Neilson A, Swift AL et al (2007) Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 292:C125-C136 (Pubitemid 46115126)
36. Yaromina A, Holscher T, Eicheler W et al (2005) Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma? Radiother Oncol 76:206-212 (Pubitemid 41725449)
37. Yaromina A, Quennet V, Zips D et al (2009) Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts. Int J Radiat Biol 85:972-980
38. Yaromina A, Zips D, Thames HD et al (2006) Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies. Radiother Oncol 81:122-129 (Pubitemid 44780780)
39. Zips D, Boke S, Kroeber T et al (2011) Prognostic Value of Radiobiological Hypoxia during Fractionated Irradiation for Local Tumor Control. Strahlenther Onkol 187:306-310